Insight
Our Investment Portfolio
Drug CRDMO
BioDuro-Sundia
Third largest global contract research, development and manufacturing organization (CRDMO) that provides biopharmaceutical partners with fully integrated services to support drug discovery, development and manufacturing for both drug substance and drug product.
Biologics CDMO
BioCina
Global, multi-product biologics contract development and manufacturing organization (CDMO), focused on development and cGMP manufacture of microbial-based therapeutics, from preclinical to commercial production.
Conditionally Active Biologics
BioAlta
Global clinical-stage biotechnology company utilizing proprietary Conditionally Active Biologics (CAB) technology to develop novel monoclonal antibody and other protein therapeutic product candidates with more selective targeting, greater efficacy, and more cost-efficient and predictable manufacturing than traditional antibodies.
Biopharmaceutical Company
Bio4T2
Preclinical biopharmaceutical company developing single-target and combo-therapeutic CAR-T therapies that are fine-tuned to comprehensively target a patient's solid tumors and their microenvironments.
Conditionally Active Biologics
Himalaya Therapeutics
Clinical stage, therapeutic company developing innovative, differentiated CAB antibody therapies in greater China. Himalaya Therapeutics strives to deliver safer, more potent cancer therapies timely and cost effectively to patients.
Preclinical Biopharmaceutical
BioArdis
Preclinical biopharmaceutical development company focusing on best-in-class small and large molecule therapeutics, and cell-therapy, to address the unmet medical needs of patients.
2015 Year invested
Automated Manufacturing of CAR-T cell
BioOra
BioOra Limited is a partnership between Bridgewest Ventures and the Malaghan Institute of Medical Research. Through automated manufacturing of CAR-T cell immunotherapy, BioOra can deliver life-saving immunotherapies at substantially less cost.
Viral Vector Production
BioViros
BioViros will be New Zealand’s first CDMO providing development services and GMP manufacturing of lentivirus vectors, both for R&D purposes and clinical trials of cell therapies.
Bionanorod-based Immunodiagnostics
Nanophage Technologies
Pioneers of the biological scalable nanorod technology platform with applications in immunodiagnostics.
Biotechnology Company
Precision Chromatography Limited
A biotechnology company that leverages patented 3D printed chromatography columns for separating and purifying biological molecules from a fluid mixture. The crucial technology serves the medicinal therapeutics industry, enabling purification of DNA, RNA, viruses, and antibodies that are used in vaccines and cell and gene therapies.
Surgical Tools
Avasa
A medical technology company with a novel revascularization device to help plastic surgeons restore form and function for patients who are left disfigured from disease and deformity.
Ophthalmic Therapeutics
TheiaNova Ltd.
TheiaNova is developing transformative, new, non-invasive therapies for patients with vision impairment due to ectatic vision disorders.
Contract Research Organization (CRO)
BioValeo Ltd.
Contract research organization (CRO) and consultation services for clinical trials specializing in CAR-T cell therapies, personalized medicines, and immunology-based treatments.
